<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_PfzSb9C">Effectiveness of mHealth Interventions in Medication Adherence among Patients with Cardiovascular Diseases: A Systematic Review</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Â© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).</p>
				</availability>
				<date type="published" when="2023-03-01">1 March 2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Muhammad</forename><surname>Arshed</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Community Health , Faculty of Medicine and Health Sciences , Universiti Putra Malaysia (UPM) , Serdang 43400 , Selangor Darul Ehsan , Malaysia</note>
								<orgName type="department" key="dep1">Department of Community Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Universiti Putra Malaysia (UPM)</orgName>
								<address>
									<addrLine>Serdang Selangor Darul Ehsan</addrLine>
									<postCode>43400</postCode>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aidalina</forename><surname>Bin Mahmud</surname></persName>
							<idno type="ORCID">0000-0001-9411-6140</idno>
						</author>
						<author>
							<persName><forename type="first">Halimatus</forename><forename type="middle">Sakdiah</forename><surname>Minhat</surname></persName>
							<idno type="ORCID">0000-0001-9411-6140</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Community Health , Faculty of Medicine and Health Sciences , Universiti Putra Malaysia (UPM) , Serdang 43400 , Selangor Darul Ehsan , Malaysia</note>
								<orgName type="department" key="dep1">Department of Community Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Universiti Putra Malaysia (UPM)</orgName>
								<address>
									<addrLine>Serdang Selangor Darul Ehsan</addrLine>
									<postCode>43400</postCode>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lim</forename><surname>Poh</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Community Health , Faculty of Medicine and Health Sciences , Universiti Putra Malaysia (UPM) , Serdang 43400 , Selangor Darul Ehsan , Malaysia</note>
								<orgName type="department" key="dep1">Department of Community Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Universiti Putra Malaysia (UPM)</orgName>
								<address>
									<addrLine>Serdang Selangor Darul Ehsan</addrLine>
									<postCode>43400</postCode>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Muhammad</forename><surname>Farooq Umer</surname></persName>
							<idno type="ORCID">0000-0001-7779-1929</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Community Health , Faculty of Medicine and Health Sciences , Universiti Putra Malaysia (UPM) , Serdang 43400 , Selangor Darul Ehsan , Malaysia</note>
								<orgName type="department" key="dep1">Department of Community Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Universiti Putra Malaysia (UPM)</orgName>
								<address>
									<addrLine>Serdang Selangor Darul Ehsan</addrLine>
									<postCode>43400</postCode>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Dental Public Health , College of Dentistry , King Faisal University , Hofuf 31982 , Saudi Arabia</note>
								<orgName type="department" key="dep1">Department of Dental Public Health</orgName>
								<orgName type="department" key="dep2">College of Dentistry</orgName>
								<orgName type="institution">King Faisal University</orgName>
								<address>
									<postCode>31982</postCode>
									<settlement>Hofuf</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_CV8DhuG">Effectiveness of mHealth Interventions in Medication Adherence among Patients with Cardiovascular Diseases: A Systematic Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2023-03-01">1 March 2023</date>
						</imprint>
					</monogr>
					<idno type="MD5">DC367715DA8228A3F5FC1675A9FB1819</idno>
					<idno type="DOI">10.3390/diseases11010041</idno>
					<note type="submission">Received: 22 November 2022 Revised: 30 January 2023 Accepted: 21 February 2023</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_pBX9TEA">mobile health</term>
					<term xml:id="_n7UVWrt">interventions</term>
					<term xml:id="_hpYt7nY">adherence</term>
					<term xml:id="_zhejyyu">cardiovascular diseases medication</term>
					<term xml:id="_9kW2N4M">patients</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_v7sDmeC"><p xml:id="_ckrv6Dq"><s xml:id="_YDVn7Uv">mHealth interventions have been reported to improve adherence to long-term therapies in chronic conditions.</s><s xml:id="_tv7tCmT">Therefore, this study aimed at determining the effectiveness of mHealth interventions in medication adherence among patients with cardiovascular diseases (CVDs), a leading cause of mortality globally.</s><s xml:id="_9dMYpSW">Relying on our inclusion criteria and the PRISMA recommendations, a literature search was carried out in the PubMed, Medline, and ProQuest databases for primary studies that investigated the impact of mHealth on medication adherence for cardiovascular disease (CVD) between 2000-2021.</s><s xml:id="_ptEM2nA">A total of 23 randomized controlled trials with 34,915 participants matched the selection criteria.</s><s xml:id="_TCJy8TR">The mHealth interventions used included text messages, mobile phone applications, and voice calls, which were used either as a single intervention or combined.</s><s xml:id="_VaE8yZg">Additionally, studies on enhancing drug adherence had contradictory findings: most of the studies elaborated positive results; however, six studies were unable to reveal any significant effect.</s><s xml:id="_ncqb6qW">Finally, a risk bias analysis revealed varying outcomes across all studies.</s><s xml:id="_zY6tKDS">This review, as a whole, supported the notion that mHealth interventions can be effective in improving adherence to CVD medication even though they could not improve adherence to all CVD medications when compared with controls.</s><s xml:id="_zfDVAaH">Further trials with more refined designs integrated with comprehensive interventions are needed to produce better health outcomes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1." xml:id="_Pw9Qeqh">Introduction</head><p xml:id="_7EQFkuj"><s xml:id="_zhaauqr">Cardiovascular diseases (CVDs) account for 17.9 million deaths annually (31% of all deaths globally) <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_XTUR6fn">It is a key contributor to premature deaths and escalating healthcare expenses <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s xml:id="_hcYWARS">Cardiovascular diseases are projected by Global Health to remain the leading cause of mortality in 2030 <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_j7W2rcD">To reduce the burden of CVDs, adequate control of CVD risk factors is required; such factors include high blood pressure, excess body weight, high blood lipids, cigarette smoking, and diabetes.</s><s xml:id="_jcxU4w9">Elevated blood pressure has been reported to be the most significant contributing factor to CVDs <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_WqMbGAn">It was indicated in the Global Burden of Disease study that each of the above-mentioned risk factors was among the top 10 causes of a loss in disability-adjusted life years <ref type="bibr" target="#b5">[6]</ref>.</s></p><p xml:id="_JeUWenR"><s xml:id="_84eJncG">Adherence is the degree to which an individual's behavior in taking medications, maintaining a diet, and implementing other lifestyle changes matches with accepted advice from a healthcare professional.</s><s xml:id="_Sfs6JGZ">Medication non-adherence is acknowledged as a leading healthcare problem that can be prevented and as a serious obstacle to improving clinical outcomes.</s><s xml:id="_TBBHx6e">Non-adherence to medication represents the leading cause of mortality for more than 60% of cardiovascular patients.</s><s xml:id="_kDKykh3">Medication use is a complex activity that is influenced by a variety of elements that include experience, beliefs, and culture.</s><s xml:id="_Wv2SN5z">Medication-taking Diseases 2023, 11, 41 2 of 18 habits might vary between different drugs.</s><s xml:id="_3DEaBpP">Faster medical care that boosts medication adherence is currently one of the most serious issues.</s><s xml:id="_mbWV4Ht">Despite efforts, randomized controlled trials have only shown a limited impact on medication-taking behavior <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s></p><p xml:id="_CpCf3aU"><s xml:id="_racucC8">Despite substantial resources being allocated to developing new regimens, nonadherence to current medications is persistent and remains an issue of public health importance.</s><s xml:id="_NA5NcYA">This is because non-adherence depletes evidence-based therapy, thereby escalating mortality rates annually and globally and thus contributing to unwarranted healthcare disbursements.</s><s xml:id="_trkYBBB">The complexity of non-adherence makes it challenging to define and accurately identify its presence in patients, leading to increased risk for worse cardiac events and a higher mortality rate.</s><s xml:id="_Abac89t">Therefore, innovative tools for assessing and screening patients for non-adherence will enhance interventions targeted at improving adherence <ref type="bibr" target="#b10">[11]</ref>.</s></p><p xml:id="_q8WSfHr"><s xml:id="_9gAWbGn">The most widely used interventions to improve cardiovascular medication adherence include unsophisticated pillboxes and calendars, while the Medication Event Monitoring System (MEMS) and blister packs have been used in randomized controlled trials (RCT).</s><s xml:id="_3VXCTfm">Other modern-day interventions commonly used include mobile applications, reminder services, automated dispensers, real-time provider feedback, networkable MEMS, and biomarkers, which can measure adherence objectively <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_KW689YZ">While the availability of these sophisticated tools could be a step in proffering a solution to the issue of non-adherence, their extensive implementation remains restricted.</s><s xml:id="_WuWp3b6">Given that most of the interventions are complicated and not cost-effective, non-adherence behavior necessitates designing and implementing cost-effective interventions.</s></p><p xml:id="_uJy5U7k"><s xml:id="_MD5BKru">With the extensive possession of mobile telephones and 5.3 billion mobile broadband global subscribers in 2018 (ICT 2018), the possibility of automation gives rise to the likelihood of designing and implementing cost-effective interventions of behavior changes to a large sample population.</s><s xml:id="_KwEePHx">In recent times, mobile health is a resource that has gained popularity.</s><s xml:id="_wfQuDW9">The use of mobile phones (mHealth) was reported as a necessity for prompt and enhanced mHealth research and yielded promising results <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_ZvatZYb">Targeting behavior modification could be accomplished with the use of mHealth technologies <ref type="bibr" target="#b12">[13]</ref>.</s></p><p xml:id="_gftwyBN"><s xml:id="_uRBaRgW">In addition, mobile phone interventions are associated with only a few adverse events (such as the probability of road traffic accidents) <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_3EB5KHs">Even if mHealth is becoming increasingly popular, there is still no proof of its effectiveness <ref type="bibr" target="#b14">[15]</ref>.</s><s xml:id="_7qGGbWe">Today, mHealth, electronic health (e-Health), and telehealth can be used as replacements for each other.</s><s xml:id="_Yqkz4ec">The Global Observatory for e-Health defined mHealth as the support of medical and public health using mobile devices, which include mobile phones, personal digital assistants (PDAs), patient monitoring devices, and wireless devices.</s></p><p xml:id="_fQzw3Pr"><s xml:id="_cBSzkqY">Even though mHealth interventions to improve medication adherence in chronic disease patients have supposedly been positive, their impact on cardiovascular disease medication adherence is still not clear, so there is an urge to find literature support to establish a causal relationship.</s><s xml:id="_GTDdYma">Therefore, this systematic review was conducted to determine the effectiveness of mHealth interventions on cardiovascular medication adherence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2." xml:id="_9nedxRd">Materials and Methods</head><p xml:id="_BWFFvKe"><s xml:id="_hHXhw5s">The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were followed when conducting this systematic review of primary studies on mobile health interventions to increase adherence to cardiovascular medication.</s><s xml:id="_uyKSpHm">By outlining the basic specifications for a protocol, the PRISMA recommendations help authors to improve the reporting of procedures for intended systematic reviews and meta-analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1." xml:id="_25AaWPb">Search Criteria</head><p xml:id="_CQCzgxH"><s xml:id="_WgM4NQB">The target population was patients with the following cardiovascular diseases: hypertension, ischemic heart disease, myocardial infarction, acute coronary syndrome, heart failure, stroke, and peripheral arterial disease.</s><s xml:id="_BRuGntG">In addition, they had undergone mHealthled interventions (WHO or ATA definition of mHealth), which were compared with the control or usual care.</s><s xml:id="_WdGhfqJ">The outcome of the study was medication adherence as primary or secondary.</s><s xml:id="_3BTARWA">The search was restricted to a time frame between 2000 (August) and 2021 (July).</s><s xml:id="_3m3f39j">Only English language studies were reviewed for reporting.</s><s xml:id="_Ke9muqp">The participants' sociodemographic characteristics (gender, age, location, education level, income, ethnicity, type of client, and years of experience) were not a limitation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2." xml:id="_XSmwv2k">Inclusion and Exclusion Criteria</head><p xml:id="_hDtA2uQ"><s xml:id="_K2rERNz">The inclusion criteria were: (1) clinical trials in comparison with the standard of care or control, (2) peer-reviewed journal articles with full text, (3) studies conducted on mHealth interventions to determine the effect on patient adherence to cardiovascular diseases, and (4) only mHealth interventions (WHO or ATA definition of mHealth).</s></p><p xml:id="_Pdn9H83"><s xml:id="_tbuDKwy">The exclusion criteria were: (1) not original research, (2) not having adherence as the primary or secondary outcome, (3) mHealth interventions not addressing cardiovascular diseases, (4) studies that lacked an appropriate control group or were not randomized, (5) studies that were not in English, and (6) trials that were terminated before their completion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3." xml:id="_89eApFt">Search Strategy</head><p xml:id="_F2VhFhq"><s xml:id="_vFEs2Nh">This review employed the use of the PubMed, MEDLINE, ProQuest, and Google Scholar databases for an electronic systematic literature search.</s><s xml:id="_rxzNZ4M">The standard for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was applied.</s><s xml:id="_9BnMqfx">The Boolean operators "and" and "or" were used in the search.</s><s xml:id="_MnJ4RNZ">The grey literature was also researched using a Google Scholar search.</s></p><p xml:id="_NctNeZR"><s xml:id="_GK8Xaw2">The articles were identified by combining Medical Subject Headings (MeSH) with Boolean operators such as: * Reminder Systems, * Text Messaging; *mobile app; *SMS; *phone call; *digital health [Cardiovascular Diseases [ * prevention &amp; control]; *coronary; *myocard; *cerebrovasc; *stroke; *heart; Cell Phone; and Medication Adherence [ * statistics &amp; numerical data]].</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4." xml:id="_v9Av3B3">Quality Evaluation</head><p xml:id="_JEhCsfu"><s xml:id="_pced95G">Cochrane's risk-of-bias assessment tool was used to analyze the studies when evaluating the bias.</s><s xml:id="_FSsG75n">Moreover, the Cochrane Handbook for Systematic Reviews of Interventions was used for the quality assessments of all trials.</s><s xml:id="_bTZQV8j">Allocation concealment, randomization, blinding concealment, attrition rates, sufficient data reporting, and non-selective reporting of outcomes were the markers used for assessing quality.</s><s xml:id="_YBpgxDE">A 2-point Likert scale (Yes <ref type="bibr" target="#b0">(1)</ref> and No (0)) was used.</s><s xml:id="_KVYCpVs">Then, studies were categorized into three classes according to their reported score: (1) a score of more than 4, which indicated a good-quality study; (2) a score of 3-4, which indicated a moderate quality; and (3) a score less than 2, which indicated a poor quality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3." xml:id="_rnzn4Eb">Result</head><p xml:id="_VYKfnYr"><s xml:id="_kaWTshk">The search of the databases identified a total of 1254 studies that were screened to comply with the eligibility criteria.</s><s xml:id="_SHVfEyS">Studies were eliminated because the content of their titles and abstracts did not meet the inclusion criteria.</s><s xml:id="_Qpz8m9Q">This systematic review did not include studies that did not use adherence measurement as an endpoint.</s><s xml:id="_cMVeUs4">A good number of studies (58) were excluded due to the wrong populations (participants other than cardiovascular diseases), wrong interventions (interventions other than mHealth intervention), adherence to medication not reported as an endpoint, and for being systematic reviews.</s><s xml:id="_crs7EGp">Twenty-three peer-reviewed journal articles met the inclusion criteria  and were taken into account in the analysis.</s><s xml:id="_UmDVy6S">The PRISMA flowchart is depicted in Figure <ref type="figure" target="#fig_0">1</ref>.</s></p><p xml:id="_xQbcm6s"><s xml:id="_RUNqQhp">Twenty-three peer-reviewed journal articles met the inclusion criteria [16-38] and were taken into account in the analysis.</s><s xml:id="_48W6PK7">The PRISMA flowchart is depicted in Figure <ref type="figure" target="#fig_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1." xml:id="_gntuvu5">Characteristics of Trials</head><p xml:id="_GcwfG2r"><s xml:id="_dgaMjdf">This section provides an overview of the authors, the study designs, the intervention subcategories, the types of intervention, the study country, the outcomes, and the adherence measurement tools.</s><s xml:id="_cDu2fFw">Adherence or correlates of adherence were used as the outcome measure.</s><s xml:id="_C9EjgX7">While the study findings provided the final results, the adherence measurement described how adherence was measured in each study.</s><s xml:id="_rDrDf94">All of these were randomized controlled trials, including seven from the USA with multiple time durations; i.e., one month, 12 months, 28 days, 12 months, 3 months, 6 months, and 3 months, respectively; the sample sizes in these studies were: 90, 21,750, 60, 253, 126, 179, and 413, respectively <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>. Two more studies from Canada had durations of 4 months and 12 months with sample sizes of 90 and 2632, respectively <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s xml:id="_s8DznYX">Three studies were conducted in China that were 6 months, 1 month, and 3 months of duration with sample sizes of 280, 50, and 445, respectively <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b36">37]</ref>.</s><s xml:id="_KFRc4eG">In addition, two studies were from Pakistan, each with a 3-month duration and with sample sizes of 200 and 201, respectively <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s xml:id="_G4CUpbr">One more study was conducted in South Africa with a 12-month duration and a sample size of 1372 <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_5NPGqWh">Some studies from other parts of world included the following: one from the United Kingdom with a duration of 6 months and a sample size of 301 <ref type="bibr" target="#b17">[18]</ref>; one from Australia</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1." xml:id="_QsnmVne">Characteristics of Trials</head><p xml:id="_54rQXYD"><s xml:id="_DSzk56P">This section provides an overview of the authors, the study designs, the intervention subcategories, the types of intervention, the study country, the outcomes, and the adherence measurement tools.</s><s xml:id="_kTcRGuw">Adherence or correlates of adherence were used as the outcome measure.</s><s xml:id="_u8MWvYY">While the study findings provided the final results, the adherence measurement described how adherence was measured in each study.</s><s xml:id="_Su5YrYR">All of these were randomized controlled trials, including seven from the USA with multiple time durations; i.e., one month, 12 months, 28 days, 12 months, 3 months, 6 months, and 3 months, respectively; the sample sizes in these studies were: 90, 21,750, 60, 253, 126, 179, and 413, respectively <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>. Two more studies from Canada had durations of 4 months and 12 months with sample sizes of 90 and 2632, respectively <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s xml:id="_99YgfKU">Three studies were conducted in China that were 6 months, 1 month, and 3 months of duration with sample sizes of 280, 50, and 445, respectively <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b36">37]</ref>.</s><s xml:id="_phd6fr9">In addition, two studies were from Pakistan, each with a 3-month duration and with sample sizes of 200 and 201, respectively <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s xml:id="_VTdsMt7">One more study was conducted in South Africa with a 12-month duration and a sample size of 1372 <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_cqzrFRT">Some studies from other parts of world included the following: one from the United Kingdom with a duration of 6 months and a sample size of 301 <ref type="bibr" target="#b17">[18]</ref>; one from Australia with a 3-month duration and a sample size of 165 <ref type="bibr" target="#b33">[34]</ref>; one from France with a 1-month duration and a sample size of 5546 <ref type="bibr" target="#b15">[16]</ref>; one from Malaysia with a 2-month duration and a sample size 62 <ref type="bibr" target="#b21">[22]</ref>; one from Iran with a 3-month duration and a sample size of 123 <ref type="bibr" target="#b25">[26]</ref>; and one from New Zealand with a duration of 12 months and a sample size of 306 <ref type="bibr" target="#b37">[38]</ref> (Table <ref type="table" target="#tab_1">1</ref>).</s><s xml:id="_E7qRCw6">In the intervention group, patient satisfaction was also higher.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2." xml:id="_QCB5kEt">Types of Intervention</head><p xml:id="_7McbzHX"><s xml:id="_3xG3AWV">The types of mobile phone-based interventions varied from single SMS interventions <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b36">37]</ref> to a combination of SMS + Micro Letter (ML) (Micro Letter platforms are open-access Kik Messenger-like programs that provide users in China with access to news and other information) <ref type="bibr" target="#b23">[24]</ref>; interactive voice interventions <ref type="bibr" target="#b18">[19]</ref>; a multifaceted intervention including medication reconciliation and tailoring; patient education; collaborative care between a pharmacist and a patient's primary care clinician and voice messaging <ref type="bibr" target="#b20">[21]</ref>; interactive text messages <ref type="bibr" target="#b24">[25]</ref>; wireless self-monitoring devices <ref type="bibr" target="#b26">[27]</ref>; a webbased app using interactive patient assistance tools <ref type="bibr" target="#b27">[28]</ref>; individual and peer comparison of reminder alarms <ref type="bibr" target="#b28">[29]</ref>; talking treatment intervention that involved SMS and voice calls <ref type="bibr" target="#b29">[30]</ref>; WeChat + a BlackBerry reminder app <ref type="bibr" target="#b30">[31]</ref>; an alert electronic reminder device (wireless pill bottle) with an automated message sent to the individual via email, text, or automated phone call <ref type="bibr" target="#b31">[32]</ref>; and advanced mobile apps <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s xml:id="_kzVmgz3">One study in Canada used mail-outs and mail-outs plus phone calls <ref type="bibr" target="#b35">[36]</ref>; a qualitative study used engagement of intervention and control groups for positive and negative adherence <ref type="bibr" target="#b34">[35]</ref>; and Text4HeartII featured educational and motivating materials to promote medication use <ref type="bibr" target="#b37">[38]</ref> (as explained in Table <ref type="table" target="#tab_1">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3." xml:id="_hCXq297">Outcome Measures</head><p xml:id="_xbYzAMr"><s xml:id="_3Vzxg78">Nine trials used the Morisky Medication Adherence Scale-8 (MMAS-8) to measure adherence <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38]</ref>, one used the Morisky Medication Adherence Scale-4 (MMAS-4) <ref type="bibr" target="#b22">[23]</ref>, one study used personal inquiry for medication adherence and electronic records <ref type="bibr" target="#b17">[18]</ref>, one used a modified version of the proportion of days covered <ref type="bibr" target="#b18">[19]</ref>, one used pillbox bin openings and electronic self-reporting <ref type="bibr" target="#b19">[20]</ref>, three used the proportion of days covered (PDC) <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b35">36]</ref>, one used the Hill bone scale <ref type="bibr" target="#b25">[26]</ref>, one used GlowCap gadgets (electronic pill bottles) <ref type="bibr" target="#b28">[29]</ref>, one trial used wireless pill bottles <ref type="bibr" target="#b31">[32]</ref>, one used arachidonic acid-induced platelet aggregation <ref type="bibr" target="#b15">[16]</ref>, one used three methods (the MMAS-8, Self-efficacy for Appropriate Medication Use (SEAMS), and a Medication Event Monitoring System (MEMS)) <ref type="bibr" target="#b16">[17]</ref>, one trial utilized missed doses of pills (two) in seven days <ref type="bibr" target="#b27">[28]</ref>, one trial assessed adherence to medications via a qualitative method that used adherence (positive or negative) <ref type="bibr" target="#b34">[35]</ref>, and one utilized the MMAS-8 and prescription records to modify behavior <ref type="bibr" target="#b37">[38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4." xml:id="_yDGVxeQ">Medication Adherence</head><p xml:id="_YtqPJsu"><s xml:id="_tCzzC3v">The studies found on enhancing drug adherence had contradictory findings: 17 studies (73.9%) reported a significant improvement in medication adherence <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b36">37]</ref>, whereas 6 studies (26%) failed to show a substantial impact of the intervention on medication adherence <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b37">38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5." xml:id="_JHq83kN">Hypertension</head><p xml:id="_PWTBhwc"><s xml:id="_5yY7EpH">In this review, nine studies were found that used blood pressure as an outcome measure along with adherence to medication <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b36">37]</ref>.</s><s xml:id="_nq2wg8b">Three trials elaborated a significant decrease in blood pressure and improved medication adherence <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b36">37]</ref>.</s><s xml:id="_QcsQb9Y">At the same time, six trials could not provide any evidence of a decrease in blood pressure <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b32">33]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6." xml:id="_ceJdtJj">Ischemic Heart Disease</head><p xml:id="_fG7J7xV"><s xml:id="_qXQBQb2">Fourteen trials assessed adherence to medication in patients with coronary heart diseases <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b37">38]</ref>.</s><s xml:id="_RdVwbtr">In addition, two trials addressed cardiac rehabilitation after myocardial infarction <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s xml:id="_skxxCkT">Ten trials showed a significant improvement in adherence to medication in patients with ischemic heart diseases <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35]</ref>, while four did not reveal any significant improvement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7." xml:id="_aqUMsvS">Heart Failure</head><p xml:id="_3AkfgCw"><s xml:id="_baTQUAs">In this review, only one study assessed the impact of mHealth on medication adherence in patients with heart failure <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_N9QhsAQ">This study, which had 60 participants and a 28-day duration, was a four-arm trial with two arms using the ePill box silent and reminder vs. smartphone silent and reminder.</s><s xml:id="_kn3F98h">No improvement in adherence to medication was documented.</s><s xml:id="_JWUXVcp">mHealth has been utilized in patients with peripheral arterial disease.</s><s xml:id="_R92njSy">However, in this review, no particular study was found to determine the impact of mHealth on adherence to medication in patients with peripheral arterial disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.8." xml:id="_J2MnQsR">Stroke</head><p xml:id="_9xswQnM"><s xml:id="_BxgXuHe">Two studies evaluated the impact of mHealth on medication adherence in patients with stroke.</s><s xml:id="_zj9wzJN">They were conducted in Pakistan with sample sizes of 200 and 201 participants and a duration of three months <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s xml:id="_rcW5krB">One reported a significant improvement in medication adherence <ref type="bibr" target="#b22">[23]</ref>, while the other failed to show substantial results <ref type="bibr" target="#b29">[30]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.9." xml:id="_7SX9vuZ">Diabetes Mellitus</head><p xml:id="_QnZH6G6"><s xml:id="_jbAMGew">One trial evaluated the effect of mHealth intervention on adherence to medication in patients with cardiovascular disease comorbidity of type 2 diabetes mellitus.</s><s xml:id="_wH8DSxk">The trial used three groups: interactive voice recognition phone calls in group 1; interactive voice recognition enhanced phone calls in group 2; and a control group with usual care in group 3.</s><s xml:id="_BGVAtWg">Both intervention groups showed results that were 2.2 percentage points higher than those of the control group (95% CI, 1.1-3.4)</s><s xml:id="_pEWjGQq">with a difference of 3.0 (95% CI, 1.9-4.2) <ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.10." xml:id="_2TbBkEb">Risk of Bias and Methodological Quality Assessment</head><p xml:id="_pJvCy9N"><s xml:id="_mub8UDh">Seven domains were scored as low, high, and unclear risk of bias.</s><s xml:id="_TApXgme">Fifteen trials were considered high-quality studies because they received good scores across at least five domains <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>, while six trials achieved good scores in less than five with a moderate quality <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28]</ref>, and two received good scores in only two of the seven domains and had a poor quality <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s xml:id="_QUNW6QJ">The bias in the included studies was systematically assessed and is presented in Figure <ref type="figure" target="#fig_2">2</ref>.</s></p><p xml:id="_BhGg9G7"><s xml:id="_mvwz4Ya">Diseases 2023, 11, x FOR PEER REVIEW 12 of 18</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.8." xml:id="_WNUbksm">Stroke</head><p xml:id="_hpbU8Xt"><s xml:id="_QTK9KvN">Two studies evaluated the impact of mHealth on medication adherence in patients with stroke.</s><s xml:id="_7PGC5su">They were conducted in Pakistan with sample sizes of 200 and 201 participants and a duration of three months <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s xml:id="_U6DGAYc">One reported a significant improvement in medication adherence <ref type="bibr" target="#b22">[23]</ref>, while the other failed to show substantial results <ref type="bibr" target="#b29">[30]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.9." xml:id="_7yNWGvv">Diabetes Mellitus</head><p xml:id="_4YhTeJU"><s xml:id="_bUgNR9P">One trial evaluated the effect of mHealth intervention on adherence to medication in patients with cardiovascular disease comorbidity of type 2 diabetes mellitus.</s><s xml:id="_WMDeCFF">The trial used three groups: interactive voice recognition phone calls in group 1; interactive voice recognition enhanced phone calls in group 2; and a control group with usual care in group 3.</s><s xml:id="_CWbU5rp">Both intervention groups showed results that were 2.2 percentage points higher than those of the control group (95% CI, 1.1-3.4)</s><s xml:id="_F3uP8z6">with a difference of 3.0 (95% CI, 1.9-4.2) <ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.10." xml:id="_vpwbjD8">Risk of Bias and Methodological Quality Assessment</head><p xml:id="_ZRKz4dP"><s xml:id="_5HqU6aq">Seven domains were scored as low, high, and unclear risk of bias.</s><s xml:id="_BvkB234">Fifteen trials were considered high-quality studies because they received good scores across at least five domains <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>, while six trials achieved good scores in less than five with a moderate quality <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28]</ref>, and two received good scores in only two of the seven domains and had a poor quality <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s xml:id="_s6EqyPn">The bias in the included studies was systematically assessed and is presented in Figure <ref type="figure" target="#fig_2">2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4." xml:id="_RQeMxjd">Discussion</head><p xml:id="_Zdqeuyr"><s xml:id="_gdEpfUB">In recent times, technology-based interventional approaches such as mHealth, eHealth, and telehealth have become essential tools.</s><s xml:id="_2UZ2GAM">mHealth technology is at the same time assessable, faster, and acceptable to the community.</s></p><p xml:id="_vyTmvQt"><s xml:id="_WHzdthh">Findings from previous studies showed improvement in medication adherence in patients after mobile health interventions.</s><s xml:id="_zjJUQea">mHealth, which has gained popularity in recent times, has attained amassed interest as a tool for enhancing health promotion interventions as well as the provision of CVD prevention in an accessible manner with a relatively lower cost.</s><s xml:id="_h6EJDFv">Moreover, mHealth has a specific potential to promote lifestyle modification and is an effective tool for improving adherence <ref type="bibr" target="#b38">[39]</ref>.</s></p><p xml:id="_YWsMJkj"><s xml:id="_JpSfWju">In the present review, studies on enhancing drug adherence had contradictory findings: 17 trials (73.9%) reported a significant improvement in medication adherence, whereas 6 studies (26%) failed to show a substantial impact of the intervention on medication adherence.</s><s xml:id="_AJdXSCj">The effectiveness of mHealth interventions on cardiovascular medication adherence has also been reported in other systematic reviews, which showed that the majority of studies reported an improvement in medication adherence and other health outcomes <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>.</s><s xml:id="_CU3NDMP">Similar findings from an existing body of literature strengthen the current review's evidence <ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref>.</s></p><p xml:id="_v6kTa3x"><s xml:id="_M68ewZg">In the current review, most of the studies used SMS only as an intervention, while some trials used SMS in combination with Micro Letters or voice calls.</s><s xml:id="_k7UaYHN">In a meta-analysis review, patients who received SMS-based interventions were found more likely to be adequately adherent than the control group <ref type="bibr" target="#b43">[44]</ref>.</s></p><p xml:id="_HkwYXdV"><s xml:id="_P8rx8S4">mHealth apps (mobile and web-based) were also another popular mHealth intervention identified in the current review.</s><s xml:id="_MRdY6AU">A review was conducted to assess the impact of mHealth apps on adherence to CVD that revealed mixed results with reasonable acceptability <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_jhvvEQR">As such, the two commonly used modes of mHealth delivery are text messaging (short messaging service or SMS) and smartphone applications <ref type="bibr" target="#b38">[39]</ref>.</s><s xml:id="_69cJ5TP">In the present review, seven studies employed the use of SMS to improve medication adherence, while five studies employed mHealth-based apps.</s><s xml:id="_QZJ8weg">Both SMS and phone applications have the ability to serve the role of a drug intake reminder, blood pressure monitor, or routine clinic appointment reminder <ref type="bibr" target="#b39">[40]</ref>.</s></p><p xml:id="_nvUkZ8G"><s xml:id="_kh53Mf3">The current review identified other mHealth technologies used that included phone calls, interactive patient support apps, interactive text messages, interactive voice calls, wireless self-monitoring gadgets, electronic pill bottle reminder devices, emails, automated messages, and phone calls.</s><s xml:id="_vDAtzkE">Similarly, numerous effective delivery strategies were identified in other systematic reviews; these included SMS <ref type="bibr" target="#b45">[46,</ref><ref type="bibr" target="#b46">47]</ref>, automated phone messages, and reminders <ref type="bibr" target="#b47">[48]</ref>.</s></p><p xml:id="_xKt7msK"><s xml:id="_BDgJBhd">However, in certain cases, the reported beneficial outcome was not always a result of the patient's choice of a particular tool.</s><s xml:id="_rzv5WKc">A study compared different interventions to determine their effects on adherence to medication.</s><s xml:id="_GV46Wms">The study used various tools that included pillboxes and smartphones.</s><s xml:id="_RjWVrA9">Smartphones reported a higher adherence score than pill counts <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_TAmvwUr">Moreover, a multifaceted intervention medication reconciliation and tailoring, patient education, collaborative care between a pharmacist and a patient's primary care clinician, and voice messaging were used <ref type="bibr" target="#b20">[21]</ref>.</s></p><p xml:id="_HFdfFze"><s xml:id="_tgpYBAa">A meta-analysis of mHealth intervention to improve adherence in chronic diseases such as diabetes mellitus, asthma, cardiovascular diseases, epilepsy, and HIV infection showed improvement in medication adherence; this included 16 randomized controlled trials <ref type="bibr" target="#b48">[49]</ref>.</s><s xml:id="_2PsnZaK">mHealth intervention had a positive impact on improving antiretroviral therapies in HIV patients and in antituberculosis treatment <ref type="bibr" target="#b48">[49]</ref>; however, cardiovascular diseases require further refined designs.</s></p><p xml:id="_2jDNkYC"><s xml:id="_HQgjr5Z">mHealth is a more personalized method that helps individuals in managing their condition using an apt and standard design form.</s><s xml:id="_53SF5sJ">It has also been found to be an efficient tool in various studies of real-time data analysis.</s><s xml:id="_TtpWUFn">A study showed interest in smartwatches because they are a potential tool and have multifunctional dimensions like a smartphone.</s></p><p xml:id="_vEccQKy"><s xml:id="_GvQwrVj">The study presented a smartwatch-based medication reminder system and also introduced an early prototype to improve medication adherence <ref type="bibr" target="#b49">[50]</ref>.</s><s xml:id="_EbMCsH8">Furthermore, it could help the clinicians to improve adherence to treatment, which could be beneficial to the the patient <ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_WkwnYEH">This has been found in different studies in which medication adherence was measured using different designs, sample sizes, intervention approaches of mHealth, adherence measuring tools, outcome measures, and the multitude of methods.</s></p><p xml:id="_Yjxdb9K"><s xml:id="_c29wQtE">Mobile health strategies are instrumental in addressing the issue of medication nonadherence, which has been a challenge in the management of chronic diseases.</s><s xml:id="_dZgvfcN">Despite the positive feedback reported regarding the effectiveness of mHealth interventions in adherence to cardiovascular medications, more studies on the cost-effectiveness of this intervention type are required, especially in resource-limited settings.</s><s xml:id="_sAzqSYe">Some studies have stated that mHealth interventions are cost-effective; for instance, an mHealth intervention study in Kenya reported a marginal cost of USD 0.02 per SMS and a weekly SMS, which represented a cost of almost USD 1 per patient annually.</s><s xml:id="_HCyXbJB">This suggested that mHealth intervention requires a minimum cost to implement but has the potential to yield effective results.</s><s xml:id="_t3V5kDg">However, it was suggested that the cost of other equipment used (as well as the training of research assistants) be included in the total cost.</s><s xml:id="_8GsyvRX">Apart from being less capital intensive, implementing this type of intervention is also convenient for both the health provider and the patient who is the recipient because messages reach the patient at any time and place.</s><s xml:id="_3HVQqXW">This intervention is also less time-consuming and curbs the problem of accessibility to the health facility because patients can communicate directly with their health providers through voice calls and phone apps.</s><s xml:id="_Dqt4zVj">It is convenient in resource-limited facilities where venues for routine health education sessions are limited or unavailable, but health information can be delivered through this medium.</s><s xml:id="_y3CJtE4">The participants in all of the chosen trials were diverse.</s><s xml:id="_RKqSmTp">The fact that they varied from one another in terms of their medical and social profiles may have influenced the results, but the authors used the data from the studies to assess how well the interventions worked.</s><s xml:id="_j9Ze4TT">Additionally, there was no established time frame for assessing therapies because adherence is a behavior that lasts a lifetime.</s><s xml:id="_BPSPpSN">Studies on enhancing drug adherence have contradictory findings, where seventeen studies (73.91%) reported significant improvement in medication adherence whereas, six studies (26.09%) failed to show a substantial impact of the intervention on medication adherence.</s><s xml:id="_epFbsJS">Overall, RCTs using various interventions in the current review showed improvement in adherence to CVDs (Figure <ref type="figure" target="#fig_4">3</ref>).</s></p><p xml:id="_gcmh378"><s xml:id="_DRhKFGv">Diseases 2023, 11, x FOR PEER REVIEW 14 of 18</s></p><p xml:id="_WgD6Kky"><s xml:id="_UaRQhfQ">The study presented a smartwatch-based medication reminder system and also introduced an early prototype to improve medication adherence <ref type="bibr" target="#b49">[50]</ref>.</s><s xml:id="_UgNzqVT">Furthermore, it could help the clinicians to improve adherence to treatment, which could be beneficial to the the patient <ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_45mAGGD">This has been found in different studies in which medication adherence was measured using different designs, sample sizes, intervention approaches of mHealth, adherence measuring tools, outcome measures, and the multitude of methods.</s><s xml:id="_hb8MCCY">Mobile health strategies are instrumental in addressing the issue of medication nonadherence, which has been a challenge in the management of chronic diseases.</s><s xml:id="_2GWdFjK">Despite the positive feedback reported regarding the effectiveness of mHealth interventions in adherence to cardiovascular medications, more studies on the cost-effectiveness of this intervention type are required, especially in resource-limited settings.</s><s xml:id="_3z8SHX8">Some studies have stated that mHealth interventions are cost-effective; for instance, an mHealth intervention study in Kenya reported a marginal cost of USD 0.02 per SMS and a weekly SMS, which represented a cost of almost USD 1 per patient annually.</s><s xml:id="_AeEy8h3">This suggested that mHealth intervention requires a minimum cost to implement but has the potential to yield effective results.</s><s xml:id="_shCrTXu">However, it was suggested that the cost of other equipment used (as well as the training of research assistants) be included in the total cost.</s><s xml:id="_57VcwrQ">Apart from being less capital intensive, implementing this type of intervention is also convenient for both the health provider and the patient who is the recipient because messages reach the patient at any time and place.</s><s xml:id="_CnXmZg6">This intervention is also less time-consuming and curbs the problem of accessibility to the health facility because patients can communicate directly with their health providers through voice calls and phone apps.</s><s xml:id="_Bjxyqg6">It is convenient in resource-limited facilities where venues for routine health education sessions are limited or unavailable, but health information can be delivered through this medium.</s><s xml:id="_JPFWscD">The participants in all of the chosen trials were diverse.</s><s xml:id="_Bjnt3sM">The fact that they varied from one another in terms of their medical and social profiles may have influenced the results, but the authors used the data from the studies to assess how well the interventions worked.</s><s xml:id="_vMmNh7X">Additionally, there was no established time frame for assessing therapies because adherence is a behavior that lasts a lifetime.</s><s xml:id="_SrHY6k8">Studies on enhancing drug adherence have contradictory findings, where seventeen studies (73.91%) reported significant improvement in medication adherence whereas, six studies (26.09%) failed to show a substantial impact of the intervention on medication adherence.</s><s xml:id="_DT8p953">Overall, RCTs using various interventions in the current review showed improvement in adherence to CVDs (Figure <ref type="figure" target="#fig_4">3</ref>).</s><s xml:id="_8dHCbxY">However, in planning a mHealth intervention, it is recommended that studies of this nature design an acceptable, standardized, systematic, and validated mobile phone application to facilitate the implementation.</s><s xml:id="_rYJkP28">In the present review, only the studies in <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b51">52]</ref> had customized applications designed for their interventions.</s><s xml:id="_SpV9vVp">Furthermore, the timing of sending messages and making calls as well as the language used must be acceptable to and understandable by the patients.</s><s xml:id="_j4PWzD5">Close attention should be paid to the content and frequency of the messages and calls to fully achieve the goal of the intervention and gain the benefits thereof.</s><s xml:id="_KmghFxK">An alternative method should be considered for patients who have problems with their sight, speech, or hearing, as well as for patients who cannot read.</s><s xml:id="_eQgsFCs">All these factors should be considered in designing mHealth interventions.</s><s xml:id="_9ZrTyau">Lastly, one of the goals of behavioral interventions is to produce lasting or durable behavioral changes that will yield positive health outcomes.</s><s xml:id="_cum6k4f">On this note, it is suggested that future research on mHealth focus on the long-term impact of this intervention on adherence behavior among cardiovascular disease patients because this will provide more authentic findings and justifications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5." xml:id="_N3rCW2u">Conclusions</head><p xml:id="_5E5Yqk9"><s xml:id="_CHHqAvt">This review, as a whole, supported the notion that mHealth interventions can be effective in improving adherence to CVD medication even though the use of various mHealth interventions could not improve adherence to all CVD medications when compared with controls.</s><s xml:id="_XNG9cuG">Further trials with more refined designs integrated with comprehensive and effective interventions are needed.</s><s xml:id="_YAtBwWw">Furthermore, cost-effectiveness studies of such interventions should be conducted to further derive the benefits of mHealth interventions.</s><s xml:id="_pNvk98A">This will enable policymakers to reserve capital-intensive interventions for patients who are most in need of such interventions; for instance, patients dealing with factors that mHealth cannot overcome (such as adverse drug reactions or a high pill burden).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_X68g2YB"><s xml:id="_5reRXwT">Figure 1.</s><s xml:id="_E5MNHww">PRISMA (2009) flow diagram showing the flow of search and analysis.</s></p></div></figDesc><graphic coords="4,68.68,84.27,455.60,404.98" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_YxrHw4w"><s xml:id="_86jSqck">Figure 1.</s><s xml:id="_D24h7aD">PRISMA (2009) flow diagram showing the flow of search and analysis.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_egmXz6D"><s xml:id="_2zcJj5p">Figure 2. Bias Risk Assessment [16-38].</s></p></div></figDesc><graphic coords="12,163.78,419.88,255.01,337.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_B64dKfQ"><s xml:id="_YBAQzyB">Figure 2. Bias Risk Assessment [16-38].</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_QmctrZk"><s xml:id="_ZmFqAXe">Figure 3. Adherence improvement in response to interventions reflected in the studies included.Figure 3. Adherence improvement in response to interventions reflected in the studies included.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_YXNyXa2"><s xml:id="_2GYeAzr">Figure 3. Adherence improvement in response to interventions reflected in the studies included.Figure 3. Adherence improvement in response to interventions reflected in the studies included.</s></p></div></figDesc><graphic coords="14,169.16,522.39,251.09,242.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_sgMmdzB"><s xml:id="_P5F9rem">Summary of impacts of a mobile health intervention on medication adherence among patients with cardiovascular diseases.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>Adherence to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1: daily</cell><cell></cell><cell></cell><cell>aspirin</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>n = 5546</cell><cell></cell><cell>SMS reminders</cell><cell></cell><cell></cell><cell>improved in</cell></row><row><cell>1</cell><cell>Quilici et al. (2013) [16]</cell><cell>RCT (1 month)</cell><cell>France</cell><cell>ACS patients after PCI on aspirin</cell><cell>AA-Ag</cell><cell>for aspirin-adherence in intervention</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>the intervention arm with SMS</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>medication</cell><cell></cell><cell>arm; Arm-2:</cell><cell></cell><cell></cell><cell>reminders with</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>control (no</cell><cell></cell><cell></cell><cell>an odds ratio of</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>0.37 to 0.02.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Text messaging</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Patients with</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>text message</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interventions</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>showed a</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell>higher</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell>percentage of</cell></row><row><cell>2</cell><cell>Park et al. (2014) [17]</cell><cell>RCT (1 month)</cell><cell>USA (Northern California)</cell><cell>n = 90 ACS patients</cell><cell>1-MMAS-8 2-SEAMS 3-MEMS</cell><cell>reminder text messages for medication; Arm-2: rext messages for education; Arm-3: control</cell><cell>Adherence</cell><cell>Patient feasibility and satisfaction with the text messages</cell><cell>accurate doses (p = 0.02), percentage of doses taken (p = 0.01), and percentage of prescribed</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(no</cell><cell></cell><cell></cell><cell>doses taken on</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>time (p = 0.01).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Antiplatelet</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>response rates</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>were higher</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>than statin</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>response rates</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.005) as</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>per the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>schedule.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>significantly</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>compared to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>the control</cell></row><row><cell>3</cell><cell>Wald et al. (2014) [18]</cell><cell>RCT (6 months)</cell><cell>UK (London)</cell><cell>n = 301 Patients on AHT + lipid-lowering medication</cell><cell>1-Personal inquiry for medication adherence 2-Electronic records for drug prescription</cell><cell>Two arm trial: Arm-1: text messaging intervention for reminders to take medication; Arm-2: control (no intervention)</cell><cell>Adherence</cell><cell>Blood pressure and serum cholesterol</cell><cell>group. Non-adherence to medication was lower among the text messaging group (14/150 (9%)) than in the control group (38/151 (25%)). No</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>statistically</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>significant</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>differences in</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>blood pressure</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>were found.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>significantly</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved in</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell>both</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1: phone</cell><cell></cell><cell></cell><cell>intervention</cell></row><row><cell>4</cell><cell>Vollmer et al. (2014) [19]</cell><cell>RCT (12 months)</cell><cell>USA (Northwest, Hawaii, and Georgia)</cell><cell>n = 21,752 CAD patients with type 2 diabetes (suboptimal adherence to medication)</cell><cell>Modified version of the PDC</cell><cell>calls (interactive voice); Arm-2: interactive voice-recognition-enhanced phone calls; Arm-3: control</cell><cell>Adherence</cell><cell>Blood pressure and lipid levels</cell><cell>groups. Both intervention groups showed 2.2 percentage points higher than the control group with odds ratios of 1.16 and 1.14</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(no</cell><cell></cell><cell></cell><cell>higher in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>first and second</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>groups than the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>control.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_ggrYxUZ"><s xml:id="_j4HEvue">Cont.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>No</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improvement</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>in adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>The total</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Four-arm</cell><cell></cell><cell></cell><cell>adherence rate</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pillbox bin</cell><cell>factorial</cell><cell></cell><cell></cell><cell>was 78% (SD</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>openings were</cell><cell>feasibility trial:</cell><cell></cell><cell></cell><cell>35), with the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>used for the</cell><cell>two arms with</cell><cell></cell><cell></cell><cell>telehealth</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>telehealth</cell><cell>pillbox silent,</cell><cell></cell><cell></cell><cell>device</cell></row><row><cell>5</cell><cell>Goldstein et al. (2014) [20]</cell><cell>RCT (28 days)</cell><cell>USA (Ohio)</cell><cell>n = 60 Patients with CF</cell><cell>intervention group and electronic</cell><cell>pillbox reminding; and two arms</cell><cell>Adherence</cell><cell>Acceptance of model</cell><cell>adhering 80% of the time and people with a</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>self-reporting for</cell><cell>with</cell><cell></cell><cell></cell><cell>smartphone</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>people with</cell><cell>smartphone</cell><cell></cell><cell></cell><cell>adhering 76%</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>them-health</cell><cell>silent,</cell><cell></cell><cell></cell><cell>of the time;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention</cell><cell>smartphone</cell><cell></cell><cell></cell><cell>reminders</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>reminding</cell><cell></cell><cell></cell><cell>adhered 79% of</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>the time while</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>reminding did</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>not improve</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved. The</cell></row><row><cell>6</cell><cell>Ho et al. (2014) [21]</cell><cell>RCT (12 months)</cell><cell>USA (Colorado, Washington, North Carolina, and Arkansas</cell><cell>n = 253 ACS/MI patients</cell><cell>PDC &gt; 0.8</cell><cell>Two-arm trial: Arm-1: multifaceted intervention, medication reconciliation and tailoring, patient education, collaborative care between a pharmacist and a patient's primary care clinician, and voice messaging; Arm-2: control</cell><cell>Adherence</cell><cell>Blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C)</cell><cell>intervention group showed 89.3% adherent patients vs. 73.9% in the usual care group (p = 0.003). In addition, the intervention arm had a greater mean proportion of days covered, with 0.94 vs. 0.87 (p = 0.001). No significant decrease in systolic blood</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>pressure was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>found.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>Adherence was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell>found to</cell></row><row><cell>7</cell><cell>Khonsari et al. (2015) [22]</cell><cell>RCT (2 months)</cell><cell>Malaysia</cell><cell>n = 62 ACS patients</cell><cell>MMAS-8</cell><cell>automated SMS reminders; Arm-2: control</cell><cell>Adherence</cell><cell>Heart functional status</cell><cell>improve by (Ï(2) (2) = 18.614, and heart functional</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(no</cell><cell></cell><cell></cell><cell>status was also</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>improved.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved by</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>7.4 in the</cell></row><row><cell>8</cell><cell>Kamal et al. (2015) [23]</cell><cell>RCT (3 months)</cell><cell>Pakistan</cell><cell>n = 200 Post-stroke patients treated for high blood pressure</cell><cell>MMAS-4</cell><cell>Two-arm trial: Arm-I: SMS for reminders to take medication; Arm-2: control (no intervention)</cell><cell>Adherence</cell><cell>DBP</cell><cell>intervention group and 6.7 in the control group, while the mean diastolic blood pressure in the intervention group was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.6 mmHg</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>lower vs. the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>control group.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell></cell></row><row><cell>9</cell><cell>Fang and Li (2016) [24]</cell><cell>RCT (6 months)</cell><cell>China</cell><cell>n = 280 CAD patients post-angiography /CT</cell><cell>MMAS-8</cell><cell>Arm-1: utilized SMS; Arm-2: utilized SMS + Micro Letter, Arm-3: control with the phone</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>Improved adherence (improved score not mentioned).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>only</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_sVup7Tz"><s xml:id="_qkRdqR9">Cont.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>odds ratio for</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>PDC was 1.86</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p &lt; 0.001) for</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>information-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>only messaging</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>vs. usual care</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and 1.60</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.002) for</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interactive</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell>messaging vs.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1: text</cell><cell></cell><cell></cell><cell>usual care.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>message</cell><cell></cell><cell></cell><cell>SBP was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Proportion of</cell><cell>reminders for</cell><cell></cell><cell></cell><cell>significantly</cell></row><row><cell>10</cell><cell>Bobrow et al. (2016) [25]</cell><cell>RCT (12 months)</cell><cell>South Africa</cell><cell>n = 1372 Hyperten-sive patients</cell><cell>days calculated + EuroQol Group 5-Dimension Self-Report</cell><cell>medication adherence; Arm-2: interactive text</cell><cell>SBP Control</cell><cell>Adherence and quality of life</cell><cell>reduced in both experimental groups; the mean change</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Questionnaire</cell><cell>messages;</cell><cell></cell><cell></cell><cell>for the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-3: control</cell><cell></cell><cell></cell><cell>information-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(usual care</cell><cell></cell><cell></cell><cell>only message</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>with no texts)</cell><cell></cell><cell></cell><cell>group vs. the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>usual care</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>group was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-2.2 mm Hg</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.046) and</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>for the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interactive</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>message group</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>vs. usual care</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>group was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-1.6 mm Hg</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.16).</cell></row><row><cell>11</cell><cell>Maslakpak and Safaie (2016) [26]</cell><cell>RCT (3 months)</cell><cell>Iran</cell><cell>n = 123 Hy-pertensive patients</cell><cell>Hill-Bone Medication Adherence Scale</cell><cell>Three-arm trial: Arm 1: SMS; Arm 2: reminder card; Arm 3: control (no intervention)</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>Improved adherence; SMS (57.70 Â± 2.75), reminder cards (57.51 Â± 2.69), vs. control (46.63 Â± 2.99) (p &lt; 0.001).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>No</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improvement</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>in adherence.</cell></row><row><cell>12</cell><cell>Kim et al. (2016) [27]</cell><cell>RCT (6 months)</cell><cell>Republic of Korea</cell><cell>n = 95 Hyperten-sive patients</cell><cell>MMAS-8</cell><cell>Arm 1: wireless self-monitoring app; Arm-2: control (no</cell><cell>Adherence, PAM, SBP, and DBP</cell><cell>Not mentioned</cell><cell>Improved SBP (beta = -0.27, p = 0.02) and DBP (beta = -0.34,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>p = 0.007) with</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>patient</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>activation.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>Score for</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell>Change in</cell><cell>non-adherence:</cell></row><row><cell>13</cell><cell>Johnston et al. (2016) [28]</cell><cell>RCT (6 months)</cell><cell>Sweden</cell><cell>n = 174 Post-MI patients</cell><cell>2 missed doses throughout a maximum 7-day observation cycle</cell><cell>interactive patient assistance tool (web-based</cell><cell>Non-adherence score</cell><cell>cardiovascu-lar risk quality of factors and</cell><cell>intervention vs. control (16.6 vs. 22.8) (p = 0.025).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>software);</cell><cell></cell><cell>life</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-2: control</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_CUuBwpx"><s xml:id="_aprb63C">Cont.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>feedback from</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>a participant</cell><cell></cell><cell></cell><cell></cell></row><row><cell>14</cell><cell>Reddy et al. (2017) [29]</cell><cell>RCT (3 months)</cell><cell>USA (Philadel-phia)</cell><cell>n = 126 30-75 years old, 65 years old, 96% male patients with CAD with poor adherence</cell><cell>GlowCap (electronic pill bottle)</cell><cell>who received a daily alarm and a weekly report on their medication adherence; Arm-2: feedback from a partner who also received an alarm and a weekly report that was shared with a</cell><cell>Adherence</cell><cell>Adherence (post-intervention) change in LDL and patient activation</cell><cell>Adherence improved in both intervention arms compared to control. Individual feedback arm: 89%; partner feedback arm: 86%; control arm: 67%; (p &lt; 0.001).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>friend, family</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>member, or</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>peer; Arm-3:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>control</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1: daily</cell><cell></cell><cell></cell><cell>improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interactive</cell><cell></cell><cell></cell><cell>insignificantly:</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>voice call, daily</cell><cell></cell><cell></cell><cell>7.41 in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>medication</cell><cell></cell><cell></cell><cell>intervention</cell></row><row><cell>15</cell><cell>Kamal et al. (2018) [30]</cell><cell>RCT (3 months)</cell><cell>Pakistan</cell><cell>n = 201 CAD + CVA patients</cell><cell>MMAS-8</cell><cell>reminder, and weekly lifestyle</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>group vs. 7.38 in the control group.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>modification</cell><cell></cell><cell></cell><cell>However, it</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>messages;</cell><cell></cell><cell></cell><cell>was not</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-2: control</cell><cell></cell><cell></cell><cell>statistically</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(no</cell><cell></cell><cell></cell><cell>significant</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>(p = 0.40).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>insignificantly;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>non-adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>reduced to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-1.35 in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>experimental</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>group vs.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-0.69 in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1-Number of</cell><cell></cell><cell></cell><cell></cell><cell>control group.</cell></row><row><cell>16</cell><cell>Ni et al. (2018) [31]</cell><cell>RCT (1 month)</cell><cell>China</cell><cell>n = 50 CHD patients</cell><cell>dosages taken by a patient 2-Voils Medication Non-Adherence Extent Scale 3-Likert scale of</cell><cell>Two-phase, two-arm trial: We Chat, BB reminder app vs. controls (no intervention)</cell><cell>Adherence</cell><cell>SBP and DBP</cell><cell>However, it was not statistically significant (p = 0.33). The SBP was reduced by 3.76</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>5 points</cell><cell></cell><cell></cell><cell></cell><cell>in controls vs.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>an increase of</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.93 in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>experimental</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>arm but this</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>was statistically</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>insignificant</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.51). DBP</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>was decreased</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>significantly.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_GEFuSdy"><s xml:id="_Fg4rbqN">Cont.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Four-arm trial:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>medication</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>n = 179</cell><cell></cell><cell>adherence</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Age: 18, 52 y;</cell><cell></cell><cell>partner</cell><cell></cell><cell></cell><cell>Adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>65% male</cell><cell></cell><cell>(friend/family);</cell><cell></cell><cell></cell><cell>improved.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>CVS Health</cell><cell></cell><cell>Arm-2: alert</cell><cell></cell><cell></cell><cell>Alert arm:</cell></row><row><cell>17</cell><cell>Kessler et al. (2018) [32]</cell><cell>RCT (6 months)</cell><cell>USA (Philadel-phia)</cell><cell>employees or their dependents with active</cell><cell>Wireless pill bottle opening</cell><cell>reminder (wireless pill bottle) + automated</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>52.9% vs. controls: 17.0% (p = 0.002); partner + alert</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>CVS</cell><cell></cell><cell>message</cell><cell></cell><cell></cell><cell>arm: 54.5% vs.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Caremark</cell><cell></cell><cell>(email, text, or</cell><cell></cell><cell></cell><cell>control: 18.6%,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>prescription</cell><cell></cell><cell>automated</cell><cell></cell><cell></cell><cell>95% (p = 0.003).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>coverage</cell><cell></cell><cell>phone calls);</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-3: alert</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and partner;</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-4: control</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>statistically</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>significant</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>change in mean</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>medication</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Two-arm trial:</cell><cell></cell><cell></cell><cell>adherence</cell></row><row><cell>18</cell><cell>Morawski et al. (2018) [33]</cell><cell>RCT (3 months)</cell><cell>USA (California)</cell><cell>n = 413 Self-reported hyperten-sion</cell><cell>MMAS-8</cell><cell>Arm-1: given a mobile app intervention; Arm-2: control (no</cell><cell>Adherence</cell><cell>SBP</cell><cell>between the smartphone app and control group (difference: 0.4;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention)</cell><cell></cell><cell></cell><cell>p = 0.01); while</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>no significant</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>change in</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>blood pressure</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>was noted</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(difference:</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-0.5; p = 0.78).</cell></row><row><cell>19</cell><cell>Santo et al. (2019) [34]</cell><cell>RCT (3 months)</cell><cell>Australia</cell><cell>n = 165 CHD patients</cell><cell>MMAS-8 and PDC</cell><cell>Three-arm trial with the usual care arm, basic medication reminder app, and advanced medication app</cell><cell>Adherence</cell><cell>Adherence according to PDC, blood pressure, and cholesterol</cell><cell>Adherence improved concerning each medicine. The app received a response from 95% of the patients.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>positive</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence as</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>an endpoint;</cell><cell></cell><cell></cell><cell></cell></row><row><cell>20</cell><cell>Desveaux et al. (2020) [35]</cell><cell>RCT (4 months)</cell><cell>Canada</cell><cell>n = 90 Post-MI patients</cell><cell>Adherence (positive and negative outcomes)</cell><cell>Arm-2: negative adherence as an outcome;</cell><cell>Adherence</cell><cell>Not mentioned</cell><cell>The intervention facilitated adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Arm-3: did not</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>involve, with</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>negative</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence as</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>an outcome.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_6ypDEVC"><s xml:id="_7PH8GQ8">Cont.</s></p></div></figDesc><table><row><cell>No.</cell><cell>Authors</cell><cell>Study Design</cell><cell>Country</cell><cell>Population</cell><cell>Adherence Measurement</cell><cell>Study Intervention</cell><cell cols="2">Outcomes Primary Secondary</cell><cell>Findings</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>No</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>improvement</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>in adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Medication</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence odds</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ratio: 1.02</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.78-1.32)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.91);</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>mail-outs: 0.95</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.68-1.10)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Three-arm trial:</cell><cell></cell><cell></cell><cell>(p = 0.73);</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>n = 2632</cell><cell></cell><cell>Arm-1:</cell><cell></cell><cell></cell><cell>mail-outs/calls</cell></row><row><cell>21</cell><cell>Ivers et al. (2020) [36]</cell><cell>RCT (12 months)</cell><cell>Ontario, Canada</cell><cell>Adults; 67 y; 70% male with CA after MI discharged</cell><cell>PDC</cell><cell>mail-outs; Arm-2: mail-outs plus automated phone calls;</cell><cell>Adherence + completion of cardiac re-habilitation</cell><cell>Not mentioned</cell><cell>Statin adherence (PDC = 0.8): 0.89 (0.69-1.16) (p = 0.39);</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>from CRC</cell><cell></cell><cell>Arm-3: control</cell><cell></cell><cell></cell><cell>mail-outs: 1.04</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(usual care)</cell><cell></cell><cell></cell><cell>(0.75-1.30).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>However, mail-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and-phone</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interventions</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>could boost</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>cardiac</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>rehabilitation</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>completion</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>after</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>myocardial</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>infarction.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Improved</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Mean</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>medication</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence: 7.4</cell></row><row><cell>22</cell><cell>Zhai et al. (2020) [37]</cell><cell>RCT (3 months)</cell><cell>China</cell><cell>n = 445 Hyperten-sive patients</cell><cell>MMAS-8</cell><cell>Two-arm cluster RCT: Arm-1: SMS-based reminders on adherence to medication vs. control (no SMS)</cell><cell>SBP DBP</cell><cell>Adherence</cell><cell>in the intervention group vs. 7.0 in the control group (p = 0.04); while SBP was reduced and showed a mean SBP of 134.5 mm Hg in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>group vs. 140.7</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>mm Hg in the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>control group</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(p = 0.001).</cell></row><row><cell>23</cell><cell>Maddison et al. (2021) [38]</cell><cell>RCT (12 months)</cell><cell>New Zealand</cell><cell>n = 306 Participants with ACS/MI/ percutaneous coronary revascular-ization</cell><cell>Prescription records, MMAS-8, A modified behaviour score (European Prospective into Cancer-Norfolk prospective population research)</cell><cell>Two-arm trial: Arm-1: Text4HeartII intervention; Arm-2: control (no intervention)</cell><cell>Adherence to medication at 24 weeks</cell><cell>Adherence to medication ratio at 52 weeks</cell><cell>No improvement in adherence. Medication adherence in intervention group vs. usual care (87/153 (56.8%) vs. 105/153).</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">RCT: randomized control trial; SBP: systolic blood pressure; DBP: diastolic blood pressure; SMS: short message</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">service; PDC: proportion of days covered; MMAS-8: Morisky Medication Adherence Scale-8; MMAS-4: Morisky</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">Medication Adherence Scale-4; ACS: acute coronary syndrome; MI: myocardial infarction; AA-Ag: arachidonic</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">acid-induced platelet aggregation; CAD: coronary artery disease; CHD: coronary heart disease; CR: cardiac</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">rehabilitation; CRC: cardiac rehabilitation center; CF: cardiac failure; MEMS: Medication Event Monitoring</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="7">System; PCI: percutaneous coronary intervention; SEAMS: Self-efficacy for Appropriate Medication Use.</cell></row></table></figure>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Zf4HgW3">Data Availability Statement:</head><p xml:id="_Tnmpyny"><s xml:id="_jHhMNxv">All accessed data for this study is shared in the manuscript.</s><s xml:id="_cWkhYuW">In case of any further requirement, 1st author can be accessed.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_jgxqwPZ"><p xml:id="_Yc5peun"><s xml:id="_N9pH7qA">Diseases 2023, <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b40">41</ref> Author Contributions: All authors contributed significantly and equally for this study.</s><s xml:id="_pvcct36">All authors have read and agreed to the published version of the manuscript.</s></p><p xml:id="_VaVd68z"><s xml:id="_VXAdHcW">Funding: This research received no external funding.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8hbG5eX">Institutional Review Board Statement:</head><p xml:id="_neye9pu"><s xml:id="_zMpVEQ2">This study did not require informed consent or ethical approval because it was an aggregate study.</s></p><p xml:id="_REjeXyb"><s xml:id="_wPbbxM6">Informed Consent Statement: This study did not require informed consent or ethical approval because it was an aggregate study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZRWWEqQ">Conflicts of Interest:</head><p xml:id="_kPKZHCF"><s xml:id="_Av9gXpC">The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_S5rdZg5">Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abajobir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abd-Allah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Abera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Abyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Aksut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alam</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2017.04.052</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dBSaW9F">J. Am. Coll. Cardiol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="1" to="25" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol. 2017, 70, 1-25. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_CwpFyQ3">Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019</title>
		<author>
			<persName><forename type="first">C</forename><surname>Abbafati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cislaghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Salman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karanikolos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mckee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Brady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Trias-LlimÃ³s</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uuexcD2">Lancet</title>
		<imprint>
			<biblScope unit="volume">396</biblScope>
			<biblScope unit="page" from="1204" to="1222" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abbafati, C.; Machado, D.B.; Cislaghi, B.; Salman, O.M.; Karanikolos, M.; McKee, M.; Abbas, K.M.; Brady, O.J.; Larson, H.J.; Trias-LlimÃ³s, S.; et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1204-1222.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_dMHJZNB">The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Mensah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fuster</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2019.10.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VYxU4rH">J. Am. Coll. Cardiol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="2529" to="2532" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mensah, G.A.; Roth, G.A.; Fuster, V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J. Am. Coll. Cardiol. 2019, 74, 2529-2532. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_HfGTWNC">Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0084204</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kBBMFDP">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">84204</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhu, Z.; Liu, Y.; Zhang, C.; Yuan, Z.; Zhang, Q.; Tang, F.; Lin, H.; Zhang, Y.; Liu, L.; Xue, F. Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study. Han W, editor. PLoS ONE 2013, 8, e84204. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_JkwrzHN">Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: Results from the Asia Pacific Cohort Studies Collaboration</title>
		<author>
			<persName><forename type="first">S</forename><surname>Peters</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Lam</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">Asia</forename><surname>Suzanne</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pacific ; Ninomiya</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knuiman</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Vaartjes</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bots</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodward</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cohort Studies Collaboration</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1136/bmjopen-2017-019335</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Rf8fK2g">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">19335</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peters, S.; Wang, X.; Lam, T.H.; Kim, H.C.; Suzanne Asia Pacific Cohort Studies Collaboration; Ninomiya, T.; Knuiman, M.; Vaartjes, I.; Bots, M.L.; Woodward, M. Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: Results from the Asia Pacific Cohort Studies Collaboration. BMJ Open 2018, 8, e019335. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_QbCjNfn">Systematic review protocol of interventions to improve the psychological well-being of general practitioners</title>
		<author>
			<persName><forename type="first">M</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13643-015-0098-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TXFxjQQ">Syst. Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">117</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murray, M.; Murray, L.; Donnelly, M. Systematic review protocol of interventions to improve the psychological well-being of general practitioners. Syst. Rev. 2015, 4, 117. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_3rjDecT">Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Conn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Ruppar</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ypmed.2017.03.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UrNJxxn">Prev. Med</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="269" to="276" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Conn, V.S.; Ruppar, T.M. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev. Med. 2017, 99, 269-276. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_ZXGsf6Q">Interventions to Improve Medication Adherence: A Review</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2018.19271</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2JXGMqP">JAMA</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="page" from="2461" to="2473" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kini, V.; Ho, P.M. Interventions to Improve Medication Adherence: A Review. JAMA. 2018, 320, 2461-2473. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_dtt65w3">e-Health interventions and improvement in treatment adherence</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sieben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J H B</forename><surname>Bredie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J H M K</forename><surname>Van Laarhoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schoonhoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A W</forename><surname>Van Onzenoort</surname></persName>
		</author>
		<idno type="DOI">10.2147/ppa.s197481</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pKSt8hT">Ned. Tijdschr. Geneeskd</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page">8460</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sieben, A.; Bredie, S.J.H.B.; van Laarhoven, C.J.H.M.K.; Schoonhoven, L.; Burger, D.M.; van Onzenoort, H.A.W. e-Health interventions and improvement in treatment adherence. Ned. Tijdschr. Geneeskd. 2014, 158, A8460.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_aXa23CY">Medication adherence interventions and outcomes: An overview of systematic reviews</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Wilhelmsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Eriksson</surname></persName>
		</author>
		<idno type="DOI">10.1136/ejhpharm-2018-001725</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G5Uydnj">Eur. J. Hosp. Pharm. Sci. Pract</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="187" to="192" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilhelmsen, N.C.; Eriksson, T. Medication adherence interventions and outcomes: An overview of systematic reviews. Eur. J. Hosp. Pharm. Sci. Pract. 2019, 26, 187-192. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_hKx9SFb">Non-adherence to cardiovascular medications</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kolandaivelu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Leiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>O'gara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Bhatt</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehu364</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E999xMj">Eur. Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="3267" to="3276" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kolandaivelu, K.; Leiden, B.B.; O&apos;Gara, P.T.; Bhatt, D.L. Non-adherence to cardiovascular medications. Eur. Heart J. 2014, 35, 3267-3276. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_vJtyC32">Mobile health technology evaluation: The mHealth evidence workshop</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Nilsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abernethy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Atienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pavel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Spruijt-Metz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2013.03.017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Yw2zBNY">Am. J. Prev. Med</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="228" to="236" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kumar, S.; Nilsen, W.J.; Abernethy, A.; Atienza, A.; Patrick, K.; Pavel, M.; Riley, W.T.; Shar, A.; Spring, B.; Spruijt-Metz, D.; et al. Mobile health technology evaluation: The mHealth evidence workshop. Am. J. Prev. Med. 2013, 45, 228-236. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_DSMa49w">Current science on consumer use of mobile health for cardiovascular disease prevention: A scientific statement from the American Heart Association</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Azar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Suffoletto</surname></persName>
		</author>
		<idno type="DOI">10.1161/cir.0000000000000232</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ArTuzEQ">Circulation</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="1157" to="1213" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burke, L.E.; Ma, J.; Azar, K.M.; Bennett, G.G.; Peterson, E.D.; Zheng, Y.; Riley, W.; Stephens, J.; Shah, S.H.; Suffoletto, B.; et al. Current science on consumer use of mobile health for cardiovascular disease prevention: A scientific statement from the American Heart Association. Circulation 2015, 132, 1157-1213. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_Z9zA9Ku">Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mariani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Tajer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">O</forename><surname>Owolabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Free</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Casas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Perel</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd011851.pub2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vguAujY">Cochrane Database Syst. Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">11851</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Adler, A.J.; Martin, N.; Mariani, J.; Tajer, C.D.; Owolabi, O.O.; Free, C.; Serrano, N.C.; Casas, J.P.; Perel, P. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2017, 4, CD011851. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_zHHSkZA">The Impact of mHealth Interventions: Systematic Review of Systematic Reviews</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Marcolino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A Q</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>; D'agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B M</forename><surname>Alkmim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Novillo-Ortiz</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.8873</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_unFFnDY">JMIR mHealth uHealth</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">8873</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marcolino, M.S.; Oliveira, J.A.Q.; D&apos;Agostino, M.; Ribeiro, A.L.; Alkmim, M.B.M.; Novillo-Ortiz, D. The Impact of mHealth Interventions: Systematic Review of Systematic Reviews. JMIR mHealth uHealth 2018, 6, e8873. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_TcPP2Tt">Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome</title>
		<author>
			<persName><forename type="first">J</forename><surname>Quilici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fugon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beguin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Morange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-L</forename><surname>Bonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-C</forename><surname>Alessi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carrieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cuisset</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijcard.2013.01.252</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nRUC5jU">Int. J. Cardiol</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="568" to="569" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Quilici, J.; Fugon, L.; Beguin, S.; Morange, P.E.; Bonnet, J.-L.; Alessi, M.-C.; Carrieri, P.; Cuisset, T. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. Int. J. Cardiol. 2013, 168, 568-569. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_PC6efpH">A text messaging intervention to promote medication adherence for patients with coronary heart disease: A randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Howie-Esquivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dracup</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2013.10.027</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ea6RWaA">Patient Educ. Couns</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="261" to="268" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Park, L.G.; Howie-Esquivel, J.; Chung, M.L.; Dracup, K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: A randomized controlled trial. Patient Educ. Couns. 2014, 94, 261-268. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_fAPhaV8">Randomised Trial of Text Messaging on Adherence to Cardiovascular Preventive Treatment (INTERACT Trial)</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Bestwick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Raiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Wald</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0114268</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nXy9Pzr">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">114268</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wald, D.S.; Bestwick, J.P.; Raiman, L.; Brendell, R.; Wald, N.J. Randomised Trial of Text Messaging on Adherence to Cardiovascular Preventive Treatment (INTERACT Trial). PLoS ONE 2014, 9, e114268. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_M248wd6">Improving adherence to cardiovascular disease medications with information technology</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Vollmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Owen-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Laws</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Ditmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Waterbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yonehara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.3121/cmr.2011.1020.c-b4-03</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xP7TjgX">Am. J. Manag. Care</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">502</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vollmer, W.M.; Owen-Smith, A.A.; O Tom, J.; Laws, R.; Ditmer, D.G.; Smith, D.H.; Waterbury, A.C.; Schneider, J.L.; Yonehara, C.H.; Williams, A.; et al. Improving adherence to cardiovascular disease medications with information technology. Am. J. Manag. Care 2014, 20, SP502.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_ESFmNGx">Randomized controlled feasibility trial of two telemedicine medication reminder systems for older adults with heart failure</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Gathright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dolansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gunstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sterns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Redle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Josephson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hughes</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x14541039</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zJcy4x9">J. Telemed. Telecare</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="293" to="299" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goldstein, C.M.; Gathright, E.C.; Dolansky, A.M.; Gunstad, J.; Sterns, A.; Redle, J.D.; Josephson, R.; Hughes, J.W. Randomized controlled feasibility trial of two telemedicine medication reminder systems for older adults with heart failure. J. Telemed. Telecare. 2014, 20, 293-299. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_5PN5BMd">Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lambert-Kerzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Fahdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Bryson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Melnyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Radcliff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mun</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2013.12944</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JmKT2Hv">JAMA Intern. Med</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="186" to="193" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ho, P.M.; Lambert-Kerzner, A.; Carey, E.P.; Fahdi, I.E.; Bryson, C.L.; Melnyk, S.D.; Bosworth, H.B.; Radcliff, T.; Davis, R.; Mun, H.; et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial. JAMA Intern. Med. 2014, 174, 186-193. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_rNsgYCW">Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome</title>
		<author>
			<persName><forename type="first">S</forename><surname>Khonsari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Subramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Latif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gholami</surname></persName>
		</author>
		<idno type="DOI">10.1177/1474515114521910</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_keA96dD">Eur. J. Cardiovasc. Nurs</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="170" to="179" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khonsari, S.; Subramanian, P.; Chinna, K.; Latif, L.A.; Ling, L.W.; Gholami, O. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur. J. Cardiovasc. Nurs. 2015, 14, 170-179. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_VMBX9Ek">A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Kamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Shaikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pasha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Azam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Memon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rehman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Akram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Affan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nazir</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12883-015-0471-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gA5cBnz">BMC Neurol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">212</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kamal, A.K.; Shaikh, Q.; Pasha, O.; Azam, I.; Islam, M.; Memon, A.A.; Rehman, H.; Akram, M.A.; Affan, M.; Nazir, S.; et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study. BMC Neurol. 2015, 15, 212. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_XnyPMxp">Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: An exploratory randomised control study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1111/jocn.12988</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KFM97Bx">J. Clin. Nurs</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="664" to="671" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fang, R.; Li, X. Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: An exploratory randomised control study. J. Clin. Nurs. 2016, 25, 664-671. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_dPRCwnU">Mobile Phone Text Messages to Support Treatment Adherence in Adults with High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bobrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Springer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shanyinde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rayner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Namane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Steyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tarassenko</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.115.017530</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_37G8zHu">Circulation</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="592" to="600" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bobrow, K.; Farmer, A.J.; Springer, D.; Shanyinde, M.; Yu, L.M.; Brennan, T.; Rayner, B.; Namane, M.; Steyn, K.; Tarassenko, L.; et al. Mobile Phone Text Messages to Support Treatment Adherence in Adults with High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial. Circulation 2016, 133, 592-600. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_EnsgMCs">A Comparison between The Effectiveness of Short Message Service and Reminder Cards Regarding Medication Adherence in Patients with Hypertension: A Randomized Controlled Clinical Trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Maslakpak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Safaie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K4BSmDK">Int. J. Community Based Nurs. Midwifery</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">209</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maslakpak, M.H.; Safaie, M. A Comparison between The Effectiveness of Short Message Service and Reminder Cards Regarding Medication Adherence in Patients with Hypertension: A Randomized Controlled Clinical Trial. Int. J. Community Based Nurs. Midwifery 2016, 4, 209.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_QRkK4AA">The Influence of Wireless Self-Monitoring Program on the Relationship Between Patient Activation and Health Behaviors, Medication Adherence, and Blood Pressure Levels in Hypertensive Patients: A Substudy of a Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Wineinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.5429</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tarxTbF">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">116</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kim, J.Y.; Wineinger, N.E.; Steinhubl, S.R. The Influence of Wireless Self-Monitoring Program on the Relationship Between Patient Activation and Health Behaviors, Medication Adherence, and Blood Pressure Levels in Hypertensive Patients: A Substudy of a Randomized Controlled Trial. J. Med. Internet Res. 2016, 18, e116. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_UPSMNab">Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study</title>
		<author>
			<persName><forename type="first">N</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bodegard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>JerstrÃ¶m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ãkesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Brorsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Alfredsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Albertsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-E</forename><surname>Karlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Varenhorst</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2016.05.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NPcgwZY">Am. Heart J</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="85" to="94" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johnston, N.; Bodegard, J.; JerstrÃ¶m, S.; Ãkesson, J.; Brorsson, H.; Alfredsson, J.; Albertsson, P.A.; Karlsson, J.-E.; Varenhorst, C. Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study. Am. Heart J. 2016, 178, 85-94. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_k7YmWx3">Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Huseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Canamucio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Long</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-016-3858-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_us3tkeT">J. Gen. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="256" to="261" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Reddy, A.; Huseman, T.L.; Canamucio, A.; Marcus, S.C.; Asch, D.A.; Volpp, K.; Long, J.A. Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial. J. Gen. Intern. Med. 2017, 32, 256-261. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_R9wqQU9">Making prescriptions &quot;talk&quot; to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Kamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Khalid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muqeet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jamil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Farhat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R A</forename><surname>Gillani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zulfiqar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Muhammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zaidi</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0197671</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XKzqF8r">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">197671</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kamal, A.K.; Khalid, W.; Muqeet, A.; Jamil, A.; Farhat, K.; Gillani, S.R.A.; Zulfiqar, M.; Saif, M.; Muhammad, A.A.; Zaidi, F.; et al. Making prescriptions &quot;talk&quot; to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS ONE 2018, 13, e0197671. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_KGPfvcj">An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Shaw</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijnss.2018.09.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wtnEydm">Int. J. Nurs. Sci</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="322" to="330" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ni, Z.; Liu, C.; Wu, B.; Yang, Q.; Douglas, C.; Shaw, R.J. An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention. Int. J. Nurs. Sci. 2018, 5, 322-330. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_Xnn4kfB">Partners and Alerts in Medication Adherence: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shrank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-018-4389-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u3ZJQTU">J. Gen. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1536" to="1542" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kessler, J.B.; Troxel, A.B.; Asch, D.A.; Mehta, S.J.; Marcus, N.; Lim, R.; Zhu, J.; Shrank, W.; Brennan, T.; Volpp, K.G. Partners and Alerts in Medication Adherence: A Randomized Clinical Trial. J. Gen. Intern. Med. 2018, 33, 1536-1542. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_AH2g3k7">Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Morawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghazinouri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krumme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lauffenburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Durfee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Oley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mohta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Haff</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2018.0447</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_skAc4Nb">JAMA Intern. Med</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="802" to="809" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morawski, K.; Ghazinouri, R.; Krumme, A.; Lauffenburger, J.C.; Lu, Z.; Durfee, E.; Oley, L.; Lee, J.; Mohta, N.; Haff, N.; et al. Asso- ciation of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial. JAMA Intern. Med. 2018, 178, 802-809. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_agkxZ4z">Evaluating Reach, Acceptability, Utility, and Engagement with An App-Based Intervention to Improve Medication Adherence in Patients with Coronary Heart Disease in the MedApp-CHD Study: A Mixed-Methods Evaluation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<idno type="DOI">10.3390/medsci7060068</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gshWJwu">Med. Sci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">68</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Santo, K.; Singleton, A.; Chow, C.K.; Redfern, J. Evaluating Reach, Acceptability, Utility, and Engagement with An App-Based Intervention to Improve Medication Adherence in Patients with Coronary Heart Disease in the MedApp-CHD Study: A Mixed-Methods Evaluation. Med. Sci. 2019, 7, 68. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_79k7u5X">How and why a multifaceted intervention to improve adherence post-MI worked for some (and could work better for others): An outcome-driven qualitative process evaluation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Desveaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saragosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mccleary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Presseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Witteman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Schwalm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Ivers</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2019-036750</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UXRuVNj">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">36750</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Desveaux, L.; Saragosa, M.; Russell, K.; McCleary, N.; Presseau, J.; Witteman, H.O.; Schwalm, J.D.; Ivers, N.M. How and why a multifaceted intervention to improve adherence post-MI worked for some (and could work better for others): An outcome-driven qualitative process evaluation. BMJ Open 2020, 10, e036750. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_NqRKJxf">Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): Pragmatic randomised controlled trial</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Ivers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Schwalm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Bouck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mccready</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taljaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Grace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bosiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Presseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Witteman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.m1731</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_24QTf86">BMJ</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page">1731</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ivers, N.M.; Schwalm, J.D.; Bouck, Z.; McCready, T.; Taljaard, M.; Grace, S.L.; Cunningham, J.; Bosiak, B.; Presseau, J.; Witteman, H.O.; et al. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): Pragmatic randomised controlled trial. BMJ 2020, 369, m1731. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_uch5QQD">Efficacy of text messaging and personal consultation by pharmacy students among adults with hypertension: Randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hayat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Atif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fang</surname></persName>
		</author>
		<idno type="DOI">10.2196/16019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P9j8WDg">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">16019</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhai, P.; Hayat, K.; Ji, W.; Li, Q.; Shi, L.; Atif, N.; Xu, S.; Li, P.; Du, Q.; Fang, Y. Efficacy of text messaging and personal consultation by pharmacy students among adults with hypertension: Randomized controlled trial. J. Med. Internet Res. 2020, 22, e16019. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_TuDehMM">An intervention to improve medication adherence in people with heart disease (text4heartii): Randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Benatar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rolleston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Estabrooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dale</surname></persName>
		</author>
		<idno type="DOI">10.2196/24952</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_un9SZ7Z">JMIR mHealth uHealth</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">24952</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maddison, R.; Jiang, Y.; Stewart, R.; Scott, T.; Kerr, A.; Whittaker, R.; Benatar, J.; Rolleston, A.; Estabrooks, P.; Dale, L. An intervention to improve medication adherence in people with heart disease (text4heartii): Randomized controlled trial. JMIR mHealth uHealth. 2021, 9, e24952. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_tTP8wb2">Breaking Barriers: Mobile Health Interventions for Cardiovascular Disease</title>
		<author>
			<persName><forename type="first">H</forename><surname>Klimis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cjca.2018.02.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A4HvTCz">Can. J. Cardiol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="905" to="913" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Klimis, H.; Thakkar, J.; Chow, C.K. Breaking Barriers: Mobile Health Interventions for Cardiovascular Disease. Can. J. Cardiol. 2018, 34, 905-913. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_dQ9ZwyV">Mobile Phone-Based Intervention in Hypertension Management</title>
		<author>
			<persName><forename type="first">N</forename><surname>Andre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wibawanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Siswanto</surname></persName>
		</author>
		<idno type="DOI">10.1155/2019/9021017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GVC52JB">Int. J. Hypertens</title>
		<imprint>
			<biblScope unit="page">9021017</biblScope>
			<date type="published" when="2019">2019. 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Andre, N.; Wibawanti, R.; Siswanto, B.B. Mobile Phone-Based Intervention in Hypertension Management. Int. J. Hypertens. 2019, 2019, 9021017. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_jXzSG9D">The role of mHealth for improving medication adherence in patients with cardiovascular disease: A systematic review</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Gandapur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kianoush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Misra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Urrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Blaha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Marvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1093/ehjqcco/qcw018</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4Z8BR9m">Eur. Hear. J. Qual. Care Clin. Outcomes</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="237" to="244" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gandapur, Y.; Kianoush, S.; Kelli, H.M.; Misra, S.; Urrea, B.; Blaha, M.J.; Graham, G.; Marvel, F.A.; Martin, S.S. The role of mHealth for improving medication adherence in patients with cardiovascular disease: A systematic review. Eur. Hear. J. Qual. Care Clin. Outcomes 2016, 2, 237-244. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_PymgG5N">Systematic Review of RCTs Assessing the Effectiveness of mHealth Interventions to Improve Statin Medication Adherence: Using the Behaviour-Change Technique Taxonomy to Identify the Techniques That Improve Adherence</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Judah</surname></persName>
		</author>
		<idno type="DOI">10.3390/healthcare9101282</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_We3TUCZ">Healthcare</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1282</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bond, Z.; Scanlon, T.; Judah, G. Systematic Review of RCTs Assessing the Effectiveness of mHealth Interventions to Improve Statin Medication Adherence: Using the Behaviour-Change Technique Taxonomy to Identify the Techniques That Improve Adherence. Healthcare 2021, 9, 1282. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_5saPDZ4">Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-D</forename><surname>Schwalm</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cjca.2016.08.017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YWU35ne">Can. J. Cardiol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="219" to="231" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gandhi, S.; Chen, S.; Hong, L.; Sun, K.; Gong, E.; Li, C.; Yan, L.L.; Schwalm, J.-D. Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. Can. J. Cardiol. 2017, 33, 219-231. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_wr7Q3DJ">Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kurup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Laba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.7667</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WeGKSsy">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="340" to="349" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thakkar, J.; Kurup, R.; Laba, T.L.; Santo, K.; Thiagalingam, A.; Rodgers, A.; Woodward, M.; Redfern, J.; Chow, C.K. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med. 2016, 176, 340-349. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_zfzWvzw">Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Al-Arkee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fabritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Haque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jalal</surname></persName>
		</author>
		<idno type="DOI">10.2196/24190</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XewmGNv">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">24190</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Al-Arkee, S.; Mason, J.; A Lane, D.; Fabritz, L.; Chua, W.; Haque, M.S.; Jalal, Z. Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis. J. Med. Internet Res. 2021, 23, e24190. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_HVFQdua">Automated telecommunication interventions to promote adherence to cardio-metabolic medications: Meta-analysis of effectiveness and meta-regression of behaviour change techniques</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kassavou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sutton</surname></persName>
		</author>
		<idno type="DOI">10.1080/17437199.2017.1365617</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CKXNVCu">Health Psychol. Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="25" to="42" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kassavou, A.; Sutton, S. Automated telecommunication interventions to promote adherence to cardio-metabolic medications: Meta-analysis of effectiveness and meta-regression of behaviour change techniques. Health Psychol. Rev. 2018, 12, 25-42. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_YZ9sbXx">The effectiveness of mobile-health behaviour change interventions for cardiovascular disease self-management: A systematic review</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pfaeffli Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maddison</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487315613462</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kzxTUYA">Eur. J. Prev. Cardiol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="801" to="817" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pfaeffli Dale, L.; Dobson, R.; Whittaker, R.; Maddison, R. The effectiveness of mobile-health behaviour change interventions for cardiovascular disease self-management: A systematic review. Eur. J. Prev. Cardiol. 2016, 23, 801-817. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_3ws2JQ7">Interventions to improve adherence to lipid-lowering medication</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Van Driel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Morledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ulep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Shaffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Deichmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dCdJJ9S">Cochrane Database Syst. Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">4371</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Driel, M.L.; Morledge, M.D.; Ulep, R.; Shaffer, J.P.; Davies, P.; Deichmann, R. Interventions to improve adherence to lipid-lowering medication. Cochrane Database Syst. Rev. 2016, 12, CD004371.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_tfZS3mY">Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Thirumurthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Camlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kabami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ssemmondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Elly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bukusi</surname></persName>
		</author>
		<idno type="DOI">10.1080/09540121.2016.1178959</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7kRuFy6">AIDS Care</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="90" to="98" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Suppl. S3</note>
	<note type="raw_reference">Thirumurthy, H.; Jakubowski, A.; Camlin, C.; Kabami, J.; Ssemmondo, E.; Elly, A.; Mwai, D.; Clark, T.; Cohen, C.; Bukusi, E.; et al. Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial. AIDS Care 2016, 28 (Suppl. S3), 90-98. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_FTtEHzT">An Approach to Improve Medication Adherence by Smart Watches</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sailer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pobiruchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wiesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meixner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_S8M4FZH">Digital Healthcare Empowering Europeans</title>
		<meeting><address><addrLine>Amsterdam, The Netherlands</addrLine></address></meeting>
		<imprint>
			<publisher>IOS Press</publisher>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sailer, F.; Pobiruchin, M.; Wiesner, M.; Meixner, G. An Approach to Improve Medication Adherence by Smart Watches. In Digital Healthcare Empowering Europeans; MIE; IOS Press: Amsterdam, The Netherlands, 2015.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_EhbhPF5">A Smartwatch-Driven Medication Management System Compliant to the German Medication Plan</title>
		<author>
			<persName><forename type="first">A</forename><surname>Keil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gegier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pobiruchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wiesner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ez6g4WJ">Stud. Health Technol. Inform</title>
		<imprint>
			<biblScope unit="volume">228</biblScope>
			<biblScope unit="page" from="185" to="189" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Keil, A.; Gegier, K.; Pobiruchin, M.; Wiesner, M. A Smartwatch-Driven Medication Management System Compliant to the German Medication Plan. Stud. Health Technol. Inform. 2016, 228, 185-189.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_xywNXvm">Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Bhutta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Casey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Charlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Coates</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(16)31012-1</idno>
		<ptr target="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31012-1/abstract#.WtGaUq8NnO4.mendeley" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5VD7rAR">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1459" to="1544" />
			<date type="published" when="2016-10-13">2016. 13 October 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang, H.; Naghavi, M.; Allen, C.; Barber, R.; Bhutta, Z.; Carter, A.; Casey, D.; Charlson, F.; Chen, A.Z.; Coates, M.; et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980- 2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1459-1544. Available online: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31012-1/abstract#.WtGaUq8NnO4.mendeley (accessed on 13 October 2022). [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" xml:id="_CWsSjcr">The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of</title>
		<imprint/>
	</monogr>
	<note>Disclaimer/Publisher&apos;s Note MDPI and/or the editor(s MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content</note>
	<note type="raw_reference">Disclaimer/Publisher&apos;s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
